🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

3 recruiting trials

for KCNT1-Related Epilepsy

A First-in-human Study of S230815 in Pediatric Participants With KCNT1-related Developmental and Epileptic Encephalopathy NCT07227857Phase 1, Phase 215 sites📍 Orange📍 Boston📍 Rochester Institut de Recherches Internationales Servier · Tests: S230815- Starting dose A, S230815- Dose B, S230815- Dose C, S230815- Dose D A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Clinical Activity of ABS-1230 in Pediatric and Young Adult Participants With KCNT1-related Epilepsy NCT07600736Phase 22 sites📍 Hackensack📍 Rochester Actio Biosciences, Inc. · Tests: ABS-1230, Placebo A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of ABS-1230 Given Orally Compared With Placebo in Healthy Participants Aged 18 to 55 Years NCT07156201Phase 11 site📍 Sydney Actio Biosciences, Inc. · Tests: ABS-1230, Placebo, Omeprazole, Voriconazole
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy